1. Global Cardiovascular Disease Risk Management in Italian Patients with Metabolic Syndrome in the Clinical Practice Setting

   • Ettore Ambrosioni
   • Arrigo F. G. Cicero
   • Claudio Borghi

   Original Research Article 03 January 2013 Pages: 37 - 45

   

2. A New Option for Therapeutic Management of Patients with Cardiovascular Disease

   • Massimo Volpe

   Current Opinion 03 January 2013 Pages: 47 - 51

   

3. The Clinical Significance of Metabolic Syndrome in Hypertension: Metabolic Syndrome Increases Cardiovascular Risk

   • Alejandro de la Sierra

   Current Opinion 03 January 2013 Pages: 53 - 57

4. The Clinical Significance of Metabolic Syndrome in Hypertension: Metabolic Syndrome Increases Cardiovascular Risk

   • Riccardo Sarzani

   Current Opinion 03 January 2013 Pages: 59 - 62

5. 2008 White Paper for Implementing Strategies and Interventions for Cardiovascular Prevention in Italy

   • Massimo Volpe

   Review Article 03 January 2013 Pages: 63 - 73

   

6. Nebivolol/Hydrochlorothiazide

   • Ettore Malacco

   Review Article 03 January 2013 Pages: 75 - 84

   

7. Dihydropiridinic Calcium-Channel Antagonists in the 2007 ESH/ESC Hypertension Guidelines

   • Giuseppe Mancia

   Review Article 03 January 2013 Pages: 85 - 90

   

8. Highlights from International Congress

   • Michel Azizi
   • Claudio Borghi
   • Massimo Volpe

   Highlights from International Congress 03 January 2013 Pages: 91 - 104